Kerry Dyson

Kerry Dyson serves as Chief Operating Officer, leading the integrated teams within CROMSOURCE committed to delivering exceptional clinical development services and flexible support to both pharmaceutical and medical device clients.

Dr Dyson has over 20 years of experience in clinical research both within the pharmaceutical and CRO sectors. During this time he has worked at all levels and across operational and commercial functions within the industry. Dr Dyson has held roles including Global Head of the Clinical Research Division, Director of Marketing and Communications and Head of UK Operations at CROMSOURCE. Within each role Dr Dyson enjoyed key responsibilities for providing strategic input to the successful growth and development of the company. Prior to joining CROMSOURCE, Dr Dyson was Head of EU Operations for Catalyst Pharma Group, and during this time his focus changed from purely operational activities to include strategic and corporate development activities. Before this time Dr Dyson worked in clinical operations at Novartis and Innovex/Quintiles.

Dr Dyson holds a PhD in Applied Physiology from Leeds Metropolitan University, an MSc in Kinesiology from McMaster University and a BSc (Hons) in Sport Science from Manchester Metropolitan University. He has authored numerous academic publications and written various articles on clinical research topics.